You are here: Scientific Experts > Boehringer Ingelheim > Fin > Finnigan > Helen A Finnigan
Helen A Finnigan
Affiliation: Boehringer Ingelheim
Hall I, Fowler A, Gupta A, Tetzlaff K, Nivens M, Sarno M, et al. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. Pulm Pharmacol Ther. 2015;32:37-44 pubmed publisher
..37% (1.57%) for montelukast (p = 0.0050 and p = 0.0657, respectively). These findings suggest that BI 671800 is associated with a small improvement in FEV1 in symptomatic controller-naÃ¯ve asthma patients, and in patients on ICS. ..